Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports.

Vuylsteke B, Reyniers T, Lucet C, Nöstlinger C, Deblonde J, Libois A, Sauvage AS, Deprez E, Goffard JC, Allard SD, Florence E, Demeester R, Callens S, Laga M.

Sex Health. 2019 Feb;16(1):80-83. doi: 10.1071/SH18071.

PMID:
30497542
2.

Physicians' preparedness for pre-exposure prophylaxis: results of an online survey in Belgium.

Reyniers T, Vuylsteke B, Pirotte B, Hoornenborg E, Bil JP, Wouters K, Laga M, Nöstlinger C.

Sex Health. 2018 Nov;15(6):606-611. doi: 10.1071/SH18072.

PMID:
30384876
3.

Case series on acute HCV in HIV-negative men in regular clinical practice: a call for action.

Boerekamps A, Wouters K, Ammerlaan HSM, Götz HM, Laga M, Rijnders BJA.

Neth J Med. 2018 Oct;76(8):374-378.

4.

Reviving old protecting group chemistry for site-selective peptide-protein conjugation.

Gunnoo SB, Iyer A, Vannecke W, Decoene KW, Hebbrecht T, Gettemans J, Laga M, Loverix S, Lasters I, Madder A.

Chem Commun (Camb). 2018 Oct 28;54(84):11929-11932. doi: 10.1039/c8cc06684a. Epub 2018 Oct 4.

PMID:
30285017
5.

Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.

Reyniers T, Nöstlinger C, Laga M, De Baetselier I, Crucitti T, Wouters K, Smekens B, Buyze J, Vuylsteke B.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):186-194. doi: 10.1097/QAI.0000000000001791.

PMID:
29975211
6.

Acute hepatitis C in HIV-negative men who have sex with men in the Netherlands and Belgium: a call for action.

Boerekamps A, Wouters K, Ammerlaan HSM, Götz HM, Laga M, Rijnders BJA.

Sex Transm Infect. 2018 Jun;94(4):297. doi: 10.1136/sextrans-2018-053526. No abstract available.

PMID:
29777055
7.

Ebola virus disease outbreak in Guinea: what effects on prevention of mother-to-child transmission of HIV services?

Leno NN, Delamou A, Koita Y, Diallo TS, Kaba A, Delvaux T, Van Damme W, Laga M.

Reprod Health. 2018 Apr 10;15(1):60. doi: 10.1186/s12978-018-0502-y.

8.

Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.

Vermeersch S, Callens S, De Wit S, Goffard JC, Laga M, Van Beckhoven D, Annemans L.

Acta Clin Belg. 2018 Feb;73(1):54-67. doi: 10.1080/17843286.2017.1339978. Epub 2017 Jul 3.

PMID:
28673201
9.

Estimating the number of female sex workers in Côte d'Ivoire: results and lessons learned.

Vuylsteke B, Sika L, Semdé G, Anoma C, Kacou E, Laga M.

Trop Med Int Health. 2017 Sep;22(9):1112-1118. doi: 10.1111/tmi.12911. Epub 2017 Jul 5.

10.

First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium.

Loos J, Nöstlinger C, Vuylsteke B, Deblonde J, Ndungu M, Kint I, Manirankunda L, Reyniers T, Adobea D, Laga M, Colebunders R.

PLoS One. 2017 Apr 5;12(4):e0174677. doi: 10.1371/journal.pone.0174677. eCollection 2017.

11.

Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol.

De Baetselier I, Reyniers T, Nöstlinger C, Wouters K, Fransen K, Crucitti T, Kenyon C, Buyze J, Schurmans C, Laga M, Vuylsteke B; Be-PrEP-Ared Study Group.

JMIR Res Protoc. 2017 Jan 30;6(1):e11. doi: 10.2196/resprot.6767.

12.

Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.

Reyniers T, Hoornenborg E, Vuylsteke B, Wouters K, Laga M.

Sex Transm Infect. 2017 Aug;93(5):363-367. doi: 10.1136/sextrans-2016-052699. Epub 2016 Nov 21. Review.

PMID:
27872326
13.

PrEP for African migrants in Europe? A research agenda.

Loos J, Nöstlinger C, Reyniers T, Colebunders R, Jespers V, Manirankunda L, Berghe WV, Vuylsteke B, Laga M.

Lancet HIV. 2016 Nov;3(11):e505-e507. doi: 10.1016/S2352-3018(16)30173-4. No abstract available.

PMID:
27788864
14.

HIV Prevention 2020: a framework for delivery and a call for action.

Dehne KL, Dallabetta G, Wilson D, Garnett GP, Laga M, Benomar E, Fakoya A, Baggaley RC, Nelson LJ, Kasedde S, Bermejo A, Warren M, Benedikt C; Global Prevention Focal Point Group.

Lancet HIV. 2016 Jul;3(7):e323-32. doi: 10.1016/S2352-3018(16)30035-2. Review.

PMID:
27365207
15.

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.

Letronne F, Laumet G, Ayral AM, Chapuis J, Demiautte F, Laga M, Vandenberghe ME, Malmanche N, Leroux F, Eysert F, Sottejeau Y, Chami L, Flaig A, Bauer C, Dourlen P, Lesaffre M, Delay C, Huot L, Dumont J, Werkmeister E, Lafont F, Mendes T, Hansmannel F, Dermaut B, Deprez B, Hérard AS, Dhenain M, Souedet N, Pasquier F, Tulasne D, Berr C, Hauw JJ, Lemoine Y, Amouyel P, Mann D, Déprez R, Checler F, Hot D, Delzescaux T, Gevaert K, Lambert JC.

EBioMedicine. 2016 Jul;9:278-292. doi: 10.1016/j.ebiom.2016.06.002. Epub 2016 Jun 2.

16.

TOGETHER Project to Increase Understanding of the HIV Epidemic Among Sub-Saharan African Migrants: Protocol of Community-Based Participatory Mixed-Method Studies.

Loos J, Vuylsteke B, Manirankunda L, Deblonde J, Kint I, Namanya F, Fransen K, Colebunders R, Laga M, Adobea D, Nöstlinger C.

JMIR Res Protoc. 2016 Mar 17;5(1):e48. doi: 10.2196/resprot.5162.

17.

Women with HIV in Indonesia: are they bridging a concentrated epidemic to the wider community?

Rahmalia A, Wisaksana R, Meijerink H, Indrati AR, Alisjahbana B, Roeleveld N, van der Ven AJ, Laga M, van Crevel R.

BMC Res Notes. 2015 Dec 9;8:757. doi: 10.1186/s13104-015-1748-x.

18.

Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in Ivory Coast: a retrospective cohort analysis.

Vuylsteke B, Semdé G, Auld AF, Sabatier J, Kouakou J, Ettiègne-Traoré V, Buvé A, Laga M.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S99-S106. doi: 10.1097/QAI.0000000000000442.

PMID:
25723997
19.

Effect of HIV prevention in key populations: evidence accumulates, time to implement.

Laga M.

Lancet Glob Health. 2013 Nov;1(5):e243-4. doi: 10.1016/S2214-109X(13)70096-2. Epub 2013 Sep 30. No abstract available.

20.

Lifelong ART for 20 million people in sub-Saharan Africa: communities will be key for success.

Decroo T, Ford N, Laga M.

Lancet Glob Health. 2014 May;2(5):e262-3. doi: 10.1016/S2214-109X(14)70038-5. Epub 2014 Apr 23. No abstract available.

21.

Exploring risk behaviors and vulnerability for HIV among men who have sex with men in Abidjan, Cote d'Ivoire: poor knowledge, homophobia and sexual violence.

Aho J, Hakim A, Vuylsteke B, Semde G, Gbais HG, Diarrassouba M, Thiam M, Laga M.

PLoS One. 2014 Jun 24;9(6):e99591. doi: 10.1371/journal.pone.0099591. eCollection 2014.

22.

Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.

Decroo T, Koole O, Remartinez D, dos Santos N, Dezembro S, Jofrisse M, Rasschaert F, Biot M, Laga M.

Trop Med Int Health. 2014 May;19(5):514-21. doi: 10.1111/tmi.12278. Epub 2014 Feb 12.

23.

A COFRADIC protocol to study protein ubiquitination.

Stes E, Laga M, Walton A, Samyn N, Timmerman E, De Smet I, Goormachtig S, Gevaert K.

J Proteome Res. 2014 Jun 6;13(6):3107-13. doi: 10.1021/pr4012443. Epub 2014 May 20.

PMID:
24816145
24.

Acardius acephalus: "headless-heartless nine-month life".

Ray S, Basak S, Ghosh PCh, Pal M, Laga M, Pradhan M.

J Obstet Gynaecol India. 2012 Dec;62(Suppl 1):16-8. doi: 10.1007/s13224-013-0358-6. Epub 2013 Feb 22. No abstract available.

25.

International mobility, sexual behaviour and HIV-related characteristics of men who have sex with men residing in Belgium.

Vanden Berghe W, Nöstlinger C, Hospers H, Laga M.

BMC Public Health. 2013 Oct 18;13:968. doi: 10.1186/1471-2458-13-968.

26.

The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response.

Simicek M, Lievens S, Laga M, Guzenko D, Aushev VN, Kalev P, Baietti MF, Strelkov SV, Gevaert K, Tavernier J, Sablina AA.

Nat Cell Biol. 2013 Oct;15(10):1220-30. doi: 10.1038/ncb2847. Epub 2013 Sep 22.

PMID:
24056301
27.

Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review.

Decroo T, Rasschaert F, Telfer B, Remartinez D, Laga M, Ford N.

Int Health. 2013 Sep;5(3):169-79. doi: 10.1093/inthealth/iht016. Epub 2013 Jul 30. Review.

PMID:
24030268
28.

What is the place of pre-exposure prophylaxis in HIV prevention?

De Man J, Colebunders R, Florence E, Laga M, Kenyon C.

AIDS Rev. 2013 Apr-Jun;15(2):102-11. Review.

PMID:
23685443
29.

Prevention of sexual transmission of HIV: real results, science progressing, societies remaining behind.

Laga M, Piot P.

AIDS. 2012 Jun 19;26(10):1223-9. doi: 10.1097/QAD.0b013e32835462b8. Review.

PMID:
22706008
30.

Epidemiological research in the HIV field: towards understanding what we do not know.

Buvé A, Laga M.

AIDS. 2012 Jun 19;26(10):1203-4. doi: 10.1097/QAD.0b013e328353bc36. No abstract available.

PMID:
22706006
31.

The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo.

Zhou L, Barão S, Laga M, Bockstael K, Borgers M, Gijsen H, Annaert W, Moechars D, Mercken M, Gevaert K, De Strooper B.

J Biol Chem. 2012 Jul 27;287(31):25927-40. doi: 10.1074/jbc.M112.377465. Epub 2012 Jun 12. Erratum in: J Biol Chem. 2012 Sep 28;287(40):33719. Gevaer, Kris [corrected to Gevaert, Kris].

32.

Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.

Alamo ST, Colebunders R, Ouma J, Sunday P, Wagner G, Wabwire-Mangen F, Laga M.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e36-45. doi: 10.1097/FTD.0b013e3182526e6a.

33.

Avahan and impact assessment.

Laga M, Moodie R.

Lancet. 2012 Mar 17;379(9820):1003-4. doi: 10.1016/S0140-6736(12)60426-7. No abstract available.

PMID:
22423880
34.

HIV and STI prevalence among female sex workers in Côte d'Ivoire: why targeted prevention programs should be continued and strengthened.

Vuylsteke B, Semdé G, Sika L, Crucitti T, Ettiègne Traoré V, Buvé A, Laga M.

PLoS One. 2012;7(3):e32627. doi: 10.1371/journal.pone.0032627. Epub 2012 Mar 5.

35.

Evaluating AVAHAN's design, implementation and impact: lessons learned for the HIV Prevention Community.

Laga M, Vuylsteke B.

BMC Public Health. 2011 Dec 29;11 Suppl 6:S16. doi: 10.1186/1471-2458-11-S6-S16. No abstract available.

36.

High prevalence of HIV and sexually transmitted infections among male sex workers in Abidjan, Cote d'Ivoire: need for services tailored to their needs.

Vuylsteke B, Semde G, Sika L, Crucitti T, Ettiegne Traore V, Buve A, Laga M.

Sex Transm Infect. 2012 Jun;88(4):288-93. doi: 10.1136/sextrans-2011-050276. Epub 2012 Feb 11.

37.

Evaluating HIV prevention effectiveness: the perfect as the enemy of the good.

Laga M, Rugg D, Peersman G, Ainsworth M.

AIDS. 2012 Apr 24;26(7):779-83. doi: 10.1097/QAD.0b013e328351e7fb.

PMID:
22313952
38.

Task-shifting to community health workers: evaluation of the performance of a peer-led model in an antiretroviral program in Uganda.

Alamo S, Wabwire-Mangen F, Kenneth E, Sunday P, Laga M, Colebunders RL.

AIDS Patient Care STDS. 2012 Feb;26(2):101-7. doi: 10.1089/apc.2011.0279. Epub 2012 Jan 6.

PMID:
22224411
39.

Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda.

Talisuna-Alamo S, Colebunders R, Ouma J, Sunday P, Ekoru K, Laga M, Wagner G, Wabwire-Mangen F.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e52-9. doi: 10.1097/QAI.0b013e318246e2aa.

40.

Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia.

Assefa Y, Kiflie A, Tekle B, Mariam DH, Laga M, Van Damme W.

J Health Serv Res Policy. 2012 Jan;17(1):24-9. doi: 10.1258/jhsrp.2011.010135. Epub 2011 Nov 17.

PMID:
22096081
41.

A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010.

Vanden Berghe W, Nostlinger C, Buvé A, Beelaert G, Fransen K, Laga M.

Euro Surveill. 2011 Jul 14;16(28). pii: 19914.

42.

Towards an improved investment approach for an effective response to HIV/AIDS.

Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M, Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, de Freitas M, Garnett G, Holmes C, Legins K, Pillay Y, Stanciole AE, McClure C, Hirnschall G, Laga M, Padian N; Investment Framework Study Group.

Lancet. 2011 Jun 11;377(9782):2031-41. doi: 10.1016/S0140-6736(11)60702-2.

PMID:
21641026
43.

Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities.

Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, Edwin W, Laga M, Van Damme W.

BMC Health Serv Res. 2011 Apr 18;11:81. doi: 10.1186/1472-6963-11-81.

44.

Linked response for prevention, care, and treatment of HIV/AIDS, STIs, and reproductive health issues: results after 18 months of implementation in five operational districts in Cambodia.

Delvaux T, Samreth S, Barr-DiChiara M, Seguy N, Guerra K, Ngauv B, Ouk V, Laga M, Mean C.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):e47-55. doi: 10.1097/QAI.0b013e318216d5cf.

PMID:
21407084
45.

Capture-recapture for estimating the size of the female sex worker population in three cities in Côte d'Ivoire and in Kisumu, western Kenya.

Vuylsteke B, Vandenhoudt H, Langat L, Semde G, Menten J, Odongo F, Anapapa A, Sika L, Buve A, Laga M.

Trop Med Int Health. 2010 Dec;15(12):1537-43. doi: 10.1111/j.1365-3156.2010.02654.x. Epub 2010 Nov 5.

46.

Heterogeneous and decreasing HIV prevalence among women seeking antenatal care in Kinshasa, Democratic Republic of Congo.

Behets F, Edmonds A, Kitenge F, Crabbé F, Laga M; PTME Group.

Int J Epidemiol. 2010 Aug;39(4):1066-73. doi: 10.1093/ije/dyq060. Epub 2010 May 7.

47.

The importance of sex-worker interventions: the case of Avahan in India.

Laga M, Galavotti C, Sundararaman S, Moodie R.

Sex Transm Infect. 2010 Feb;86 Suppl 1:i6-7. doi: 10.1136/sti.2009.039255. No abstract available. Erratum in: Sex Transm Infect. 2010 Jun;86(3):250. Sundaramon, Sundar [corrected to Sundararaman, Sundar].

48.

Learning and doing: operational research and access to HIV treatment in Africa.

Katzenstein D, Koulla-Shiro S, Laga M, Moatti JP.

AIDS. 2010 Jan;24 Suppl 1:S1-4. doi: 10.1097/01.aids.0000366077.37827.0a. No abstract available.

PMID:
20023435
49.

Making HIV prevention programmes work.

Bertozzi SM, Laga M, Bautista-Arredondo S, Coutinho A.

Lancet. 2008 Sep 6;372(9641):831-44. doi: 10.1016/S0140-6736(08)60889-2. Epub 2008 Aug 5.

PMID:
18687457
50.

Methylglyoxal suppresses TNF-alpha-induced NF-kappaB activation by inhibiting NF-kappaB DNA-binding.

Laga M, Cottyn A, Van Herreweghe F, Vanden Berghe W, Haegeman G, Van Oostveldt P, Vandekerckhove J, Vancompernolle K.

Biochem Pharmacol. 2007 Aug 15;74(4):579-89. Epub 2007 Jun 3.

PMID:
17617381

Supplemental Content

Support Center